IRIS Institutional Research Information System - OPENBS Open Archive UniBS

BOSSI, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.836
EU - Europa 2.777
AS - Asia 2.109
AF - Africa 19
OC - Oceania 17
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 4
Totale 15.776
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.799
CN - Cina 945
UA - Ucraina 841
HK - Hong Kong 662
IE - Irlanda 377
DE - Germania 358
IT - Italia 355
SG - Singapore 342
PL - Polonia 337
GB - Regno Unito 181
FI - Finlandia 138
SE - Svezia 88
VN - Vietnam 59
IN - India 53
CZ - Repubblica Ceca 37
CA - Canada 33
FR - Francia 27
AU - Australia 16
TR - Turchia 12
EG - Egitto 10
BE - Belgio 8
CH - Svizzera 7
JP - Giappone 7
MY - Malesia 7
BR - Brasile 5
EU - Europa 4
MA - Marocco 4
MK - Macedonia 4
RU - Federazione Russa 4
AR - Argentina 3
ID - Indonesia 3
IR - Iran 3
NL - Olanda 3
RO - Romania 3
EC - Ecuador 2
ES - Italia 2
HR - Croazia 2
KR - Corea 2
MX - Messico 2
PK - Pakistan 2
TH - Thailandia 2
TN - Tunisia 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
FK - Isole Falkland (Malvinas) 1
IL - Israele 1
IQ - Iraq 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
SA - Arabia Saudita 1
SI - Slovenia 1
Totale 15.776
Salva come PNG Salva come JPEG
Città #
Fairfield 2.231
Ashburn 1.083
Seattle 903
Woodbridge 898
Jacksonville 846
Houston 769
Cambridge 694
Wilmington 668
Hong Kong 658
Princeton 636
Chandler 416
Warsaw 337
Dublin 335
New York 326
Ann Arbor 282
Beijing 218
Singapore 210
Des Moines 157
Nanjing 156
San Diego 150
Helsinki 126
Brescia 105
Shenyang 69
London 59
Changsha 58
Dong Ket 58
Hebei 52
Jinan 52
Nanchang 52
Shanghai 52
Jiaxing 49
Tianjin 46
Menlo Park 43
Pune 40
Brno 33
Milan 32
Rome 31
Kilburn 26
Ningbo 26
Los Angeles 24
Norwalk 22
Toronto 21
Taizhou 18
Boardman 16
Haikou 16
Hangzhou 16
San Francisco 16
Munich 14
Dearborn 13
Rende 13
New Bedfont 12
Guangzhou 11
Cairo 10
Chiswick 10
Frankfurt am Main 10
Lanzhou 10
Washington 10
Zhengzhou 10
Canberra 9
Hanover 8
Brooklyn 7
Brussels 7
Cazzago San Martino 7
Hounslow 7
Verona 7
Fuzhou 6
Lappeenranta 6
Melbourne 6
Taiyuan 6
Augusta 5
Lancaster 5
Leawood 5
Prescot 5
Wandsworth 5
Arezzo 4
Bonn 4
Paris 4
Petaling Jaya 4
Redwood City 4
Santa Clara 4
Tokyo 4
Turin 4
Acton 3
Amsterdam 3
Berlin 3
Central 3
Gunzenhausen 3
Kocaeli 3
Kunming 3
Lucca 3
Markham 3
Mountain View 3
Nagold 3
Ozzano dell'Emilia 3
Phoenix 3
Skopje 3
Southwark 3
Venezia 3
Victoria 3
Villa Di Tirano 3
Totale 13.441
Salva come PNG Salva come JPEG
Nome #
Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: vitamins, minerals, and nutritional supplements. 162
Systematic review of photobiomodulation for the managementof oral mucositis in cancer patients and clinical practice guidelines 160
Prognostic Nomograms in Oral Squamous Cell Carcinoma: The Negative Impact of Low Neutrophil to Lymphocyte Ratio 158
Pretreatment DWI with Histogram Analysis of the ADC in Predicting the Outcome of Advanced Oropharyngeal Cancer with Known Human Papillomavirus Status Treated with Chemoradiation 150
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 139
Tumor biomarkers for the prediction of distant metastasis in head and neck squamous cell carcinoma 128
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus 121
Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm? 119
Clinical and histological prognostic factors of recurrent and/or metastatic salivary gland adenoid cystic carcinoma 113
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 109
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact 107
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions 106
Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus 105
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus 104
Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines - part 2: honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents 102
Investigational drugs for head and neck cancer 94
Precision medicine in rare tumors and the need for multicenter trials and international collaboratives: Sinonasal cancer as paradigm 94
Absence of ALK and MET alterations in head and neck sarcomatoid carcinoma 92
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures 91
Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy 90
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 88
The 8th TNM classification for oral squamous cell carcinoma: What is gained, what is lost, and what is missing 87
Safety and feasibility of every-other-week maintenance cetuximab after first-line chemotherapy in patients with recurrent or metastatic head and neck squamous cell cancer 86
Hope in cancer patients: the relational domain as a crucial factor 86
Malignant tumors of the maxillary sinus: Prognostic impact of neurovascular invasion in a series of 138 patients 85
Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma 85
Risk of oral and gastrointestinal mucosal injury among patients receiving selected targeted agents: a meta-analysis 83
The Case Volume Issue in Head and Neck Oncology 82
Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers 81
T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results 81
Receptor tyrosine kinase profiles and human papillomavirus status in oropharyngeal squamous cell carcinoma 81
Primary resistances to EGFR inhibitors (EGFRi) in HPV-positive and -negative oropharyngeal squamous cell carcinoma (OSCC) 81
The role of systemic therapy in the management of sinonasal cancer: A critical review 81
Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review 80
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study 80
Health care-associated infections in patients with head and neck cancer treated with chemotherapy and/or radiotherapy 80
Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma 79
Mining of self-organizing map gene-expression portraits reveals prognostic stratification of HPV-positive head and neck squamous cell carcinoma 79
Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy 78
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study 78
Role of EGFR family receptors in proliferation of squamous carcinoma cells induced by wound healing fluids of head and neck cancer patients 77
TP53 mutations in head and neck cancer 77
Multikinase inhibitors in thyroid cancer 77
TP53 Mutations and Pathologic Complete Response to Neoadjuvant Cisplatin and Fluorouracil Chemotherapy in Resected Oral Cavity Squamous Cell Carcinoma 76
NICSO: Network Italiano Cure di Supporto in Oncologia - Italian Network for Supportive Care in Oncology 76
Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements 76
Comments on "Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: Patterns of failure" by Chan and Coll 75
Folate in head and neck squamous cell cancer chemoprevention: Purposely left out? 75
Prolonged response using gefitinib followed by sirolimus for advanced cutaneous squamous cell carcinoma 75
Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinoma 75
Optimizing approaches to head and neck cancer. Metastatic head and neck cancer: new options 75
Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients 75
Receptor Tyrosine Kinase Profiles and Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma 75
Pain related to cancer treatments and diagnostic procedures: a no man's land? 75
Gene-expression profiles of primary and metastatic lesions in head and neck squamous cell carcinoma 74
Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab 74
Resistance to Hedgehog inhibitor through Smoothened receptor mutation in basal cell carcinoma 74
Assessing Preferences in Patients with Head and Neck Squamous Cell Carcinoma: Phase I and II of Questionnaire Development 74
Differential impact of cisplatin dose intensity on human papillomavirus (HPV)-related (+) and HPV-unrelated (-) locoregionally advanced head and neck squamous cell carcinoma (LAHNSCC) 73
Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor 73
Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs) 73
Prognostic role of PI3KCA and TP53 in HPV-negative oropharyngeal cancers (OPCs) 73
Searching for Evidence to Support the Use of Ginger in the Prevention of Chemotherapy-Induced Nausea and Vomiting 72
Circulating pretreatment Epstein Barr Virus DNA quantification as a prognostic factor in nasopharyngeal cancer patients in a non endemic area 72
Emerging tyrosine kinase inhibitors for head and neck cancer 72
Feasibility and activity of docetaxel, cisplatinum and 5-fluorouracil induction chemotherapy followed by concurrent chemo-radiotherapy (including IMRT) in locally advanced undifferentiated nasopharyngeal cancer (LANPC) 72
Cisplatin dose intensity correlates with outcome in patients with locally advanced head and neck squamous cell carcinoma receiving concurrent cisplatin based chemoradiation: a multi-institutional experience 72
Induction chemotherapy within a multimodality treatment of nasal cavity and ethmoid sinus malignant epithelial tumours: report of an homogeneous series of patients 72
Surveillance of Patients with Head and Neck Cancer with an Intensive Clinical and Radiologic Follow-up 72
Role of induction chemotherapy in the multimodal management of locally advanced epithelial sinonasal cancer 71
Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients 71
The Benefit of a Multidisciplinary Approach to the Patient Treated with (Chemo) Radiation for Head and Neck Cancer 71
Italian version of the MD Anderson Symptom Inventory-Head and Neck Module: linguistic validation 70
CISPLATIN DOSE INTENSITY CORRELATES WITH OUTCOME IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA RECEIVING CONCURRENT CISPLATIN BASED CHEMORADIATION: A MULTI-INSTITUTIONAL EXPERIENCE 70
Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis 70
Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancer 70
Radiotherapy for unresectable sinonasal cancers: Dosimetric comparison of intensity modulated radiation therapy with coplanar and non-coplanar volumetric modulated arc therapy 69
OROPHARYNGEAL SQUAMOUS CELL CARCINOMA TREATED WITH RADIOTHERAPY OR RADIOCHEMOTHERAPY: PROGNOSTIC ROLE OF TP53 AND HPV STATUS 69
Isolating p16-positive/HPV-negative Oropharyngeal Cancer: An Effort Worth Making 69
Palifermin in Prevention of Head and Neck Cancer Radiation-Induced Mucositis: Not Yet a Definitive Word on Safety and Efficacy Profile 69
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma 69
Rapid-Onset Opioids for the Treatment of Breakthrough Cancer Pain: Two Cases of Drug Abuse 69
Pain management in head and neck cancer patients undergoing chemo-radiotherapy: Clinical practical recommendations 68
New insights in chemotherapy 68
Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data 68
Gastrointestinal toxicities from targeted therapies: measurement, duration and impact 68
Global cancer control: responding to the growing burden, rising costs and inequalities in access 68
Induction chemotherapy prior to surgery with or without postoperative radiotherapy for oral cavity cancer patients: Systematic review and meta-analysis 68
How Many Therapeutic Options Are There for Recurrent or Metastatic Salivary Duct Carcinoma? 68
Postoperative radiotherapy with volumetric modulated arc therapy of lacrimal gland carcinoma: two case reports and literature review 67
Dissecting heterogeneity and molecular mechanisms involved in paranasal sinus cancer 67
Comprehensive meta-analysis of publicly available microarray data in head and neck cancer 67
Nausea and vomiting during the first 3 intercycle periods in chemo-naive cancer patients receiving moderately/highly emetogenic therapy 67
Do not throw the baby out with the bathwater: SELECT a personalized, de-escalated lenvatinib schedule allows response in locally advanced DTC while controlling major drug-related bleeding 67
Comment on "Acute toxicity of three versus two courses of cisplatin for radiochemotherapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN): A matched pair analysis", by Rades et coll 66
Comment on 'Impact of intra-arterial chemotherapy including internal carotid artery for advanced paranasal sinus cancers involving the skull base' 66
Sinonasal Malignancies of Anterior Skull Base Histology-driven Treatment Strategies 66
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 66
Role of induction chemotherapy in the multimodal management of locally advanced epithelial sinonasal cancer 65
Detecting characteristics of nodal invasion in advanced squamocellular oral cavity cancer through a gene expression profile on primary tumor 65
Totale 8.248
Salva come PNG Salva come JPEG
Categoria #
all - tutte 119.022
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.022
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.171 0 116 142 434 236 386 485 392 301 383 206 90
2020/20215.199 64 476 246 999 298 729 152 519 345 723 284 364
2021/20222.337 116 253 56 283 109 212 76 202 120 195 201 514
2022/20231.518 359 89 46 113 92 464 8 96 144 26 37 44
2023/20242.385 64 36 117 107 122 577 90 137 665 39 33 398
2024/202549 32 17 0 0 0 0 0 0 0 0 0 0
Totale 16.172